News
17hon MSN
Find insight on Regis Healthcare, CSPC Pharmaceutical and more in the latest Market Talks covering the health care sector.
15hon MSN
Trump's NIH cuts are gutting university labs that fuel Big Pharma's drug pipeline and pushing U.S. biotech jobs, research, ...
23h
MedPage Today on MSNMonotherapy for CLLThe initial report of monotherapy with the BCL-2 inhibitor venetoclax showed it had durable clinical activity and favorable ...
Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...
This trial evaluated the safety, tolerability, pharmacodynamics, pharmacokinetics and clinical activity of AstraZeneca’s ...
Astrazeneca (AZN) concluded the recent trading session at $73.55, signifying a -1.17% move from its prior day's close.
Explore more
An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design ...
An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design ...
AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for ...
AstraZeneca has signed an AI-led research agreement with China’s CSPC Pharmaceutical Group worth up to $5.3 billion, which ...
7h
Stockhead on MSNDr Boreham’s Crucible: Sizing up the opportunity for ASX biotech AdheriumPlenty folk have an asthma puffer but few seem to know how to use it. Adherium says its Hailie device is improving compliance ...
Building the future of health care: the need for investment in radiopharmaceutical commercialization
The efforts of CNIC and CMIE are setting the stage for this future, ensuring that Canada remains at the cutting edge of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results